Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pramipexole

Known as: (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine, Pramipexol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United… Expand
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Depression is common in patients with Parkinson's disease, but evidence on the efficacy of antidepressants in this… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Continuous dopaminergic drug delivery is an unmet medical need in advanced Parkinson's disease. The aim of this trial… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND The best way to initiate dopaminergic therapy for early Parkinson disease remains unclear. OBJECTIVE To compare… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND The original serotonergic and noradrenergic hypotheses do not fully account for the neurobiology of depression or… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Previous studies suggest that the dopamine agonist pramipexole may possess antidepressant properties. The authors… Expand
  • table 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
  • JAMA
  • 2002
  • Corpus ID: 19529337
CONTEXT Pramipexole and levodopa are effective medications to treat motor symptoms of early Parkinson disease (PD). In vitro and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
CONTEXT Pramipexole and levodopa both ameliorate the motor symptoms of early Parkinson disease (PD), but no controlled studies… Expand
  • table 2
  • table 3
  • figure 3
  • table 5
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Pramipexole, a dopamine D2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Article abstract The authors report a new side effect of the dopamine agonists pramipexole and ropinirole: sudden irresistible… Expand
Is this relevant?